Closed System Bioprocessing Market Poised for Strong Growth Through 2033 as Demand for Sterile, Scalable Biomanufacturing Accelerates, Unlocking New Opportunities Across Products and Applications
Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Closed System Bioprocessing Market Size, Share & Trends Analysis Report by Product, Application, End Use, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.
Global Closed System Bioprocessing Market to Reach USD 21.37 Billion by 2033
The global closed system bioprocessing market was valued at USD 10.95 billion in 2025 and is projected to reach USD 21.37 billion by 2033, expanding at a compound annual growth rate of 8.90% from 2026 to 2033. Market growth is being supported by the increasing adoption of single-use bioprocessing technologies, rising production of biologics, and continued investment in cell and gene therapy manufacturing.
Biopharmaceutical companies are prioritizing closed system bioprocessing solutions to strengthen contamination control, improve operational efficiency, and support compliance with Good Manufacturing Practice requirements. Growing demand for flexible manufacturing environments and standardized workflows is also accelerating the implementation of closed bioprocessing equipment across research, clinical, and commercial production facilities.
Contamination Control and Product Quality Support Market Growth
Closed system bioprocessing is gaining significant traction because it limits environmental exposure and reduces human intervention during biologics manufacturing. Sealed, sterile pathways are particularly important for sensitive products, including monoclonal antibodies, vaccines, recombinant proteins, biosimilars, and cell-based therapies.
By reducing contamination risks, closed bioprocessing systems can help manufacturers prevent batch failures, product recalls, and regulatory non-compliance. These systems also promote process consistency, sterility assurance, and traceability throughout manufacturing operations. The integration of automation further reduces manual handling, supports reproducibility, and lowers the potential for process variability and batch rejection.
Biologics, Vaccines, and Advanced Therapies Drive Demand
Expanding global demand for biologics and vaccines remains a major growth driver for the closed system bioprocessing market. Manufacturers are investing in scalable, sterile, and efficient production technologies to accommodate increasingly complex therapeutic pipelines while maintaining product stability and quality.
The rapid development of cell and gene therapies, regenerative medicine, and personalized treatments is creating additional market opportunities. Closed systems support aseptic and automated manufacturing workflows while enabling faster production timelines and greater facility flexibility. These capabilities are increasingly important for advanced therapies that require strict process control, reliable chain of custody, and consistent production outcomes.
Global Closed System Bioprocessing Market Segmentation
The market report analyzes revenue growth and key trends across product, application, end-use, and regional segments from 2021 to 2033.
Product Outlook
Application Outlook
End-Use Outlook
Regional Outlook
The geographic analysis covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Country-level coverage includes the U.S., Canada, Mexico, the UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, Thailand, South Korea, Brazil, Argentina, South Africa, Saudi Arabia, the UAE, and Kuwait.
Reasons to Purchase the Report
The report provides market estimates, forecasts, trend analysis, competitive intelligence, and strategic insights for organizations operating across the global bioprocessing industry. It is designed to support informed decision-making among pharmaceutical manufacturers, biotechnology companies, contract manufacturing organizations, investors, suppliers, and research institutions seeking opportunities in the expanding closed system bioprocessing market.
Key Attributes:
Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Closed System Bioprocessing Market: Product Business Analysis
4.1. Product Segment Dashboard
4.2. Global Closed System Bioprocessing Market Product Movement Analysis
4.3. Global Closed System Bioprocessing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Bioreactors
4.4.1. Global Bioreactors Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Fermenters
4.5.1. Global Fermenters Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Mixing Systems
4.6.1. Global Mixing Systems Market Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Filtration Systems
4.7.1. Global Filtration Systems Market Estimates and Forecasts, 2021-2033 (USD Million)
4.8. Others
4.8.1. Global Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Closed System Bioprocessing Market: Application Business Analysis
5.1. Application Segment Dashboard
5.2. Global Closed System Bioprocessing Market Application, Movement Analysis
5.3. Global Closed System Bioprocessing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Biopharmaceutical Production
5.4.1. Global Biopharmaceutical Production Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Vaccine Manufacturing
5.5.1. Global Vaccine Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Cell and Gene Therapy
5.6.1. Global Cell and Gene Therapy Market Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Regenerative Medicine
5.7.1. Global Regenerative Medicine Market Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Others
5.8.1. Global Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Closed System Bioprocessing Market: End Use Business Analysis
6.1. End Use Segment Dashboard
6.2. Global Closed System Bioprocessing Market End Use Movement Analysis
6.3. Global Closed System Bioprocessing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical & Biotech Companies
6.4.1. Global Pharmaceutical & Biotech Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Contract Manufacturing Organizations
6.5.1. Global Contract Manufacturing Organizations Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Research & Academic Institutes
6.6.1. Global Research & Academic Institutes Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Closed System Bioprocessing Market: Regional Estimates & Trend Analysis by Product Type, Technology, Application, & End Use.
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
7.3. North America
7.3.1. North America Closed System Bioprocessing Market Estimates and Forecasts, 2021-2033 (USD Million)
7.3.2. U.S.
7.3.3. Canada
7.3.4. Mexico
7.4. Europe
7.4.1. Europe Closed System Bioprocessing Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.2. UK
7.4.3. Germany
7.4.4. France
7.4.5. Italy
7.4.6. Spain
7.4.7. Denmark
7.4.8. Sweden
7.4.9. Norway
7.5. Asia-Pacific
7.5.1. Asia-Pacific Closed System Bioprocessing Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.2. Japan
7.5.3. China
7.5.4. India
7.5.5. Australia
7.5.6. Thailand
7.5.7. South Korea
7.6. Latin America
7.6.1. Latin America Closed System Bioprocessing Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.2. Brazil
7.6.3. Argentina
7.7. MEA
7.7.1. MEA Closed System Bioprocessing Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.2. South Africa
7.7.3. Saudi Arabia
7.7.4. UAE
7.7.5. Kuwait
Chapter 8. Competitive Landscape
8.1. Participant Categorization
8.2. Strategy Mapping
8.3. Company Market Share/ Position Analysis, 2025
8.4. Participant's Overview
8.4.1. Thermo Fisher Scientific
8.4.2. Sartorius AG
8.4.3. Merck KGaA
8.4.4. GE Healthcare (Cytiva)
8.4.5. Danaher Corporation
8.4.6. Eppendorf AG
8.4.7. Lonza Group
8.4.8. Corning Incorporated
8.4.9. Pall Corporation
8.4.10. Applikon Biotechnology
8.4.11. PBS Biotech
8.4.12. Miltenyi Biotec
8.4.13. Fujifilm Diosynth Biotechnologies
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 4 Global closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 5 Global closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 6 Global closed system bioprocessing market, by region, 2021-2033 (USD Million)
Table 7 North America closed system bioprocessing market, by country, 2021-2033 (USD Million)
Table 8 North America closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 9 North America closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 10 North America closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 11 U.S. closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 12 U.S. closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 13 U.S. closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 14 Canada closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 15 Canada closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 16 Canada closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 17 Mexico closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 18 Mexico closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 19 Mexico closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 20 Europe closed system bioprocessing market, by country, 2021-2033 (USD Million)
Table 21 Europe closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 22 Europe closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 23 Europe closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 24 UK closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 25 UK closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 26 UK closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 27 Germany closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 28 Germany closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 29 Germany closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 30 France closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 31 France closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 32 France closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 33 Italy closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 34 Italy closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 35 Italy closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 36 Spain closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 37 Spain closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 38 Spain closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 39 Denmark closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 40 Denmark closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 41 Denmark closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 42 Sweden closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 43 Sweden closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 44 Sweden closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 45 Norway closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 46 Norway closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 47 Norway closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 48 Asia-Pacific closed system bioprocessing market, by country, 2021-2033 (USD Million)
Table 49 Asia-Pacific closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 50 Asia-Pacific closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 51 Asia-Pacific closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 52 Japan closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 53 Japan closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 54 Japan closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 55 China closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 56 China closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 57 China closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 58 India closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 59 India closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 60 Australia closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 61 Australia closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 62 Australia closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 63 Thailand closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 64 Thailand closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 65 Thailand closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 66 South Korea closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 67 South Korea closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 68 South Korea closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 69 Latin America closed system bioprocessing market, by country, 2021-2033 (USD Million)
Table 70 Latin America closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 71 Latin America closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 72 Latin America closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 73 Brazil closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 74 Brazil closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 75 Brazil closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 76 Argentina closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 77 Argentina closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 78 Argentina closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 79 Middle East & Africa closed system bioprocessing market, by country, 2021-2033 (USD Million)
Table 80 Middle East & Africa closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 81 Middle East & Africa closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 82 Middle East & Africa closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 83 South Africa closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 84 South Africa closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 85 South Africa closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 86 Saudi Arabia closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 87 Saudi Arabia closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 88 Saudi Arabia closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 89 UAE closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 90 UAE closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 91 UAE closed system bioprocessing market, by end use, 2021-2033 (USD Million)
Table 92 Kuwait closed system bioprocessing market, by product, 2021-2033 (USD Million)
Table 93 Kuwait closed system bioprocessing market, by application, 2021-2033 (USD Million)
Table 94 Kuwait closed system bioprocessing market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Closed system bioprocessing market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Parent market outlook
Figure 11 Closed system bioprocessing market driver analysis
Figure 12 Closed system bioprocessing market restraint analysis
Figure 13 Closed system bioprocessing market: Porter's analysis
Figure 14 Closed system bioprocessing market: PESTEL analysis
Figure 15 Closed system bioprocessing market: Product outlook and key takeaways
Figure 16 Closed system bioprocessing market: Product market share analysis, 2025-2033
Figure 17 Global closed system bioprocessing market by bioreactors market, 2021-2033 (USD Million)
Figure 18 Global closed system bioprocessing market by fermenters market, 2021-2033 (USD Million)
Figure 19 Global closed system bioprocessing market by mixing systems market, 2021-2033 (USD Million)
Figure 20 Global closed system bioprocessing market by filtration systems market, 2021-2033 (USD Million)
Figure 21 Global closed system bioprocessing market by others market, 2021-2033 (USD Million)
Figure 22 Closed system bioprocessing market: Application outlook and key takeaways
Figure 23 Closed system bioprocessing market: Application market share analysis, 2025-2033
Figure 24 Global closed system bioprocessing market by biopharmaceutical production market, 2021-2033 (USD Million)
Figure 25 Global closed system bioprocessing market by vaccine manufacturing market, 2021-2033 (USD Million)
Figure 26 Global closed system bioprocessing market by cell and gene therapy market, 2021-2033 (USD Million)
Figure 27 Global closed system bioprocessing market by regenerative medicine market, 2021-2033 (USD Million)
Figure 28 Global closed system bioprocessing market by others market, 2021-2033 (USD Million)
Figure 29 Closed system bioprocessing market: End Use outlook and key takeaways
Figure 30 Closed system bioprocessing market: End Use market share analysis, 2025-2033
Figure 31 Global closed system bioprocessing market by pharmaceutical & biotech companies market, 2021-2033 (USD Million)
Figure 32 Global closed system bioprocessing market by contract manufacturing organizations market, 2021-2033 (USD Million)
Figure 33 Global closed system bioprocessing market by research & academic institutes market, 2021-2033 (USD Million)
Figure 34 Regional marketplace: Key takeaways
Figure 35 North America closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 36 U.S. closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 37 Canada closed system bioprocessing market, 2021-2033 (USD Million)
Figure 38 Mexico closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 39 Europe closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 40 UK closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 41 Germany closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 42 France closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 43 Italy closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 44 Spain closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 45 Denmark closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 46 Sweden closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 47 Norway closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 48 Asia-Pacific closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 49 Japan closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 50 China closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 51 India closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 52 Australia closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 53 Thailand closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 54 South Korea closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 55 Latin America closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 56 Brazil closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 57 Argentina closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 58 MEA closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 59 South Africa closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 60 Saudi Arabia closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 61 UAE closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Figure 62 Kuwait closed system bioprocessing market estimates and forecast, 2021-2033 (USD Million)
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/nwij61
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.